Menu

Editorial Board 

CNS

René-Olivier Mirimanoff, Faculty of Biology and Médicine, University of Lausanne, Lausanne, Switzerland
Patrick Roth, Department of Neurology, University Hospital Zurich, Zurich, Switzerland 

Dermatological

Iris Zalaudek, Division of Dermatology and Venerology, Medical University of Graz, Graz, Austria 

Gastrointestinal

George Demetri, Harvard Medical School, Ludwig Center at Harvard and Center for Sarcoma and Bone Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston MA, USA
Guy Eslick, Nepean Hospital, New South Wales, Australia
Enrique Grande, Ramon y Cajal University Hospital, Madrid, Spain
George Pentheroudakis, Medical School University of Ioannina, Greece
Philip A. Philip, Wayne State University School of Medicine and the Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA 

Gynaecological

Maurie Markman, Drexel University College of Medicine, Philadelphia, PA, USA

Head and neck

Athanassios Argiris, University of Texas, San Antonio, TX, USA
Alba Brandes, Azienda USL di Bologna, Bologna, Italy
Alfio Ferlito, University of Udine, Udine, Italy 

Hematological

Massimo Breccia, Sapienza University of Rome, Rome, Italy
H.C. Rüdiger Hehlmann, Medizinische Fakultät Mannheim der Universität Heidelberg, Heidelberg, Germany
Yok-Lam Kwong, University of Hong Kong, and Li Ka Shing Faculty of Medicine, Hong Kong, China
Livio Pagano, Istituto di Ematologia, Università Cattolica S. Cuore, Rome, Italy
Xavier Thomas, Centre Hospitalier Lyon Sud, Pierre Benite, France
David Valcárcel, Hospital Universitari Vall d'Hebron, Barcelona, Spain

Lung

Michele Carbone, University of Hawaii Cancer Center and John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA 

Pathology

Ralf Rieker, Department of Pathology, University of Heidelberg, Heidelberg, Germany 

Sarcomas

Javier Martín-Broto, Hospital Universitario son Espases, Palma de Mallorca, Spain 

Thoracic

Hedy Lee Kindler, The University of Chicago Medicine, Chicago, IL, USA

 

Advisory Reviewer Board

 As well as the aforementioned therapy areas, Oncology and Therapy additionally has an Advisory Reviewer Board consisting of internationally renowned and active clinicians, clinical academics, healthcare professionals and health policy experts across all areas of oncological therapy and cancer-related conditions, including device-related therapies, who provide peer review of manuscripts submitted to the journal and assist the editors in development of the journal.

Alberto Broniscer, Michelle A. Casey, Filomena Cetani, Avani Changela, Chih-Shan Jason Chen, Lawrence H. Einhorn, A. Emre E┼čkazan, Saurabh Ghosh Roy, Richard E. Hautmann, Viive M. Howell, Hagop M. Kantarjian, Yannis Metaxas, Heiblig Maël, Svenja Nölting, James H. Park, Madhukiran Parvathaneni, Dongjun Peng, Friedhelm Raue, K. Thomas Robbins, Nicholas Rowell, Shikha Saini, Marc Sanson, Manuj Tandon, Eswar Tipireneni, Eric Winquist, Jinghang Xie

Recruitment

As Oncology and Therapy continues to go from strength to strength, we are constantly looking to expand our esteemed Editorial and Advisory Reviewer Boards, and include within them individuals who may want to further their editorial experience within their range of expertise. With this in mind, if you would like to represent your research community as part of our boards, please email helen.fowler@springer.com with the following information: Name, title (Mr/Mrs/Dr/Prof), profession, affiliation/institution or company, country, telephone number, area(s) of expertise, and a brief Curriculum Vitae (CV).

 

↑ Back to top